Sunshine Biopharma (SBFMW) Stock: Why It's Down Today
Updated Oct 19, 2026, 4:00 PM ET · closing price
- Closed at $0.03, -0.40% vs the prior close of $0.03.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)
SBFMW dips 0.4% to $0.03. Closed at $0.03, -0.40% vs the prior close of $0.03. Day range $0.03–$0.03, opened at $0.24.
SBFMW daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — SBFMW dips 0.4% to $0.03
- Closed at $0.03, -0.40% vs the prior close of $0.03. Day range $0.03–$0.03, opened at $0.24.
- 52-week range $0.03–$0.03; today's close sits at 0% of that range, 0.4% below the 52-week high.
SBFMW bull case vs bear case (from the data)
- Annual revenue grew 4.1% in the latest fiscal year (SEC XBRL).
- Share count down 14.9% in a year (buybacks).
- Latest fiscal-year net income: loss of $5.98M.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
SBFMW latest news & SEC filings
Every SEC filing by or about SBFMW in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form PRE 14C — PRE 14C filing
PRE 14C filing
Oct 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Oct 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 13, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 8.01 — Reported other events the company considers important.
Oct 9, 2026 · Form 424B4 — Final prospectus with offering price
Final prospectus with offering price
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 5, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 2, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 28, 2026 · Form DEF 14C — DEF 14C filing
DEF 14C filing
Sep 16, 2026 · Form PRE 14C — PRE 14C filing
PRE 14C filing
Sep 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Sep 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade SBFMW
- Last results release: Apr 9, 2026 (8-K Item 2.02). Previous ones: May 19, 2025, Apr 2, 2025, Nov 7, 2024. Based on that rhythm, the next report is likely around Jul 9, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.40% (largest 0.4%). That is a relatively calm stock.
- Liquidity: about 300 shares (≈$8) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.03 vs a range of $0.03–$0.03 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 14, 2026; 8-K Oct 9, 2026; 8-K Sep 16, 2026.
- Share count: 3.88M shares outstanding (Aug 13, 2026), -14.9% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
SBFMW market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 0.24 | 0.03 | 0.03 | 0.03 | 600 |
| Oct 15, 2026 | 0.24 | 0.03 | 0.03 | 0.03 | 0 |
About Sunshine Biopharma
Sunshine Biopharma (SBFMW) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in FORT LAUDERDALE, FL. State of incorporation: CO. Fiscal year ends December 31. SEC CIK 1402328.
SBFMW board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| David Natan | Director | Aug 11, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
SBFMW financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $36.31M | $-5.98M | — | $-5.33M |
| Dec 31, 2024 | $34.87M | $-5.13M | -7.32 | $-12.52M |
| Dec 31, 2023 | $24.09M | $-4.51M | -351.36 | $-8.78M |
| Dec 31, 2022 | $4.35M | $-26.74M | -1.76 | $-5.25M |
| Dec 31, 2021 | $228.43K | $-12.44M | -4.76 | $-1.83M |
Latest balance sheet: total assets $33.63M, total liabilities $6.09M, cash $19.73M (as of Jun 30, 2026).
SBFMW earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Apr 9, 2026 | 8-K Item 2.02 (results) | — |
| May 19, 2025 | 8-K Item 2.02 (results) | — |
| Apr 2, 2025 | 8-K Item 2.02 (results) | — |
| Nov 7, 2024 | 8-K Item 2.02 (results) | — |
| Aug 19, 2024 | 8-K Item 2.02 (results) | — |
| May 22, 2024 | 8-K Item 2.02 (results) | — |
| Apr 1, 2024 | 8-K Item 2.02 (results) | — |
| Nov 13, 2023 | 8-K Item 2.02 (results) | — |
| Aug 11, 2023 | 8-K Item 2.02 (results) | — |
| May 11, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on SBFMW
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.